{"transactions":[{"id":714440,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share option (right to buy)","published_at":"2026-07-06T22:04:55.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":152207,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable annually in substantially equal installments over a three-year period, with the first tranche vested on July 1, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":152207,"derivative":{"exercise_price":7.85,"expiration_date":"2036-07-01","underlying":"Common Shares","underlying_shares":152207},"source":{"system":"sec-edgar","filing":"0001628280-26-047396","document":"wk-form4_1783375492.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620368/000162828026047396/wk-form4_1783375492.xml","form_type":"4"}},{"id":726439,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-25T22:00:04.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":6068,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this stock option shall vest in full upon the earlier to occur of (i) June 24, 2027 and (ii) the date of the next annual meeting of the Issuer's stockholders."}],"balance_after":6068,"derivative":{"exercise_price":99.87,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":6068},"source":{"system":"sec-edgar","filing":"0001193125-26-283135","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000119312526283135/ownership.xml","form_type":"4"}},{"id":742670,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-06-10T20:13:05.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award will fully vest upon the earlier of (a) the Issuer's next annual stockholder meeting, or (b) the one-year anniversary of the grant date, such to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":38000,"derivative":{"exercise_price":3.94,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0001620368-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620368/000162036826000003/primarydocument.xml","form_type":"4"}},{"id":750849,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-06-03T21:03:16.000Z","date":"2026-06-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":12600,"price":3.08,"value":38808.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of Common Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted share units previously granted."}],"balance_after":140686,"source":{"system":"sec-edgar","filing":"0001628280-26-040491","document":"wk-form4_1780520592.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1620368/000162828026040491/wk-form4_1780520592.xml","form_type":"4"}},{"id":750848,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-06-03T21:03:16.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the annual grant of restricted stock units (\"RSUs\") made under the Issuer's 2019 Equity Incentive Plan for service as a Director. The RSUs vest on the earlier of (i) one year from the grant date or (ii) the date of the 2027 Annual Meeting of Shareholders, subject to the Reporting Person's continued service to the Issuer.  Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":153286,"source":{"system":"sec-edgar","filing":"0001628280-26-040491","document":"wk-form4_1780520592.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620368/000162828026040491/wk-form4_1780520592.xml","form_type":"4"}},{"id":970683,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2025-12-12T23:54:53.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 29, 2025, Merus N.V. (the \"Issuer\") entered into a transaction agreement (as it may be amended, supplemented or otherwise modified from time to time, the \"Transaction Agreement\") with Genmab A/S (\"Genmab\") and its wholly owned subsidiary, Genmab Holding II B.V. (the \"Purchaser\"). Pursuant to the terms of the Transaction Agreement, the Purchaser commenced a tender offer for all the issued and outstanding common shares, par value EUR 0.09 per share (the \"Shares\"), of the Issuer (the \"Offer\"), and, on December 12, 2025 (the \"Acceptance Time\"), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer as of the Acceptance Time in exchange for a cash payment equal to $97.00 per Share, without interest and less applicable withholding taxes (the \"Offer Consideration\"), which Offer Consideration will be paid as soon as practicable following the Acceptance Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was cancelled pursuant to the Transaction Agreement in exchange for cash (without interest and net of applicable withholding tax and other applicable deductions) in an amount equal to the product of (i) the amount by which the Offer Consideration exceeds the applicable exercise price per Share of such option and (ii) the aggregate number of Shares underlying such option."}],"balance_after":0,"derivative":{"exercise_price":14.39,"expiration_date":"2029-01-10","underlying":"Common Shares","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001193125-25-317939","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1620368/000119312525317939/ownership.xml","form_type":"4"}},{"id":970682,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2025-12-12T23:54:53.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8631,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 29, 2025, Merus N.V. (the \"Issuer\") entered into a transaction agreement (as it may be amended, supplemented or otherwise modified from time to time, the \"Transaction Agreement\") with Genmab A/S (\"Genmab\") and its wholly owned subsidiary, Genmab Holding II B.V. (the \"Purchaser\"). Pursuant to the terms of the Transaction Agreement, the Purchaser commenced a tender offer for all the issued and outstanding common shares, par value EUR 0.09 per share (the \"Shares\"), of the Issuer (the \"Offer\"), and, on December 12, 2025 (the \"Acceptance Time\"), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer as of the Acceptance Time in exchange for a cash payment equal to $97.00 per Share, without interest and less applicable withholding taxes (the \"Offer Consideration\"), which Offer Consideration will be paid as soon as practicable following the Acceptance Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was cancelled pursuant to the Transaction Agreement in exchange for cash (without interest and net of applicable withholding tax and other applicable deductions) in an amount equal to the product of (i) the amount by which the Offer Consideration exceeds the applicable exercise price per Share of such option and (ii) the aggregate number of Shares underlying such option."}],"balance_after":0,"derivative":{"exercise_price":16.09,"expiration_date":"2030-06-30","underlying":"Common Shares","underlying_shares":8631},"source":{"system":"sec-edgar","filing":"0001193125-25-317939","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1620368/000119312525317939/ownership.xml","form_type":"4"}},{"id":970681,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2025-12-12T23:54:53.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":6120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 29, 2025, Merus N.V. (the \"Issuer\") entered into a transaction agreement (as it may be amended, supplemented or otherwise modified from time to time, the \"Transaction Agreement\") with Genmab A/S (\"Genmab\") and its wholly owned subsidiary, Genmab Holding II B.V. (the \"Purchaser\"). Pursuant to the terms of the Transaction Agreement, the Purchaser commenced a tender offer for all the issued and outstanding common shares, par value EUR 0.09 per share (the \"Shares\"), of the Issuer (the \"Offer\"), and, on December 12, 2025 (the \"Acceptance Time\"), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer as of the Acceptance Time in exchange for a cash payment equal to $97.00 per Share, without interest and less applicable withholding taxes (the \"Offer Consideration\"), which Offer Consideration will be paid as soon as practicable following the Acceptance Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was cancelled pursuant to the Transaction Agreement in exchange for cash (without interest and net of applicable withholding tax and other applicable deductions) in an amount equal to the product of (i) the amount by which the Offer Consideration exceeds the applicable exercise price per Share of such option and (ii) the aggregate number of Shares underlying such option."}],"balance_after":0,"derivative":{"exercise_price":21.15,"expiration_date":"2031-05-28","underlying":"Common Shares","underlying_shares":6120},"source":{"system":"sec-edgar","filing":"0001193125-25-317939","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1620368/000119312525317939/ownership.xml","form_type":"4"}},{"id":970680,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2025-12-12T23:54:53.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":16604,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 29, 2025, Merus N.V. (the \"Issuer\") entered into a transaction agreement (as it may be amended, supplemented or otherwise modified from time to time, the \"Transaction Agreement\") with Genmab A/S (\"Genmab\") and its wholly owned subsidiary, Genmab Holding II B.V. (the \"Purchaser\"). Pursuant to the terms of the Transaction Agreement, the Purchaser commenced a tender offer for all the issued and outstanding common shares, par value EUR 0.09 per share (the \"Shares\"), of the Issuer (the \"Offer\"), and, on December 12, 2025 (the \"Acceptance Time\"), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer as of the Acceptance Time in exchange for a cash payment equal to $97.00 per Share, without interest and less applicable withholding taxes (the \"Offer Consideration\"), which Offer Consideration will be paid as soon as practicable following the Acceptance Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was cancelled pursuant to the Transaction Agreement in exchange for cash (without interest and net of applicable withholding tax and other applicable deductions) in an amount equal to the product of (i) the amount by which the Offer Consideration exceeds the applicable exercise price per Share of such option and (ii) the aggregate number of Shares underlying such option."}],"balance_after":0,"derivative":{"exercise_price":18.56,"expiration_date":"2032-05-31","underlying":"Common Shares","underlying_shares":16604},"source":{"system":"sec-edgar","filing":"0001193125-25-317939","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1620368/000119312525317939/ownership.xml","form_type":"4"}},{"id":970679,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2025-12-12T23:54:53.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":14414,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 29, 2025, Merus N.V. (the \"Issuer\") entered into a transaction agreement (as it may be amended, supplemented or otherwise modified from time to time, the \"Transaction Agreement\") with Genmab A/S (\"Genmab\") and its wholly owned subsidiary, Genmab Holding II B.V. (the \"Purchaser\"). Pursuant to the terms of the Transaction Agreement, the Purchaser commenced a tender offer for all the issued and outstanding common shares, par value EUR 0.09 per share (the \"Shares\"), of the Issuer (the \"Offer\"), and, on December 12, 2025 (the \"Acceptance Time\"), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer as of the Acceptance Time in exchange for a cash payment equal to $97.00 per Share, without interest and less applicable withholding taxes (the \"Offer Consideration\"), which Offer Consideration will be paid as soon as practicable following the Acceptance Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was cancelled pursuant to the Transaction Agreement in exchange for cash (without interest and net of applicable withholding tax and other applicable deductions) in an amount equal to the product of (i) the amount by which the Offer Consideration exceeds the applicable exercise price per Share of such option and (ii) the aggregate number of Shares underlying such option."}],"balance_after":0,"derivative":{"exercise_price":23.29,"expiration_date":"2033-06-08","underlying":"Common Shares","underlying_shares":14414},"source":{"system":"sec-edgar","filing":"0001193125-25-317939","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1620368/000119312525317939/ownership.xml","form_type":"4"}},{"id":970678,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2025-12-12T23:54:53.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8844,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 29, 2025, Merus N.V. (the \"Issuer\") entered into a transaction agreement (as it may be amended, supplemented or otherwise modified from time to time, the \"Transaction Agreement\") with Genmab A/S (\"Genmab\") and its wholly owned subsidiary, Genmab Holding II B.V. (the \"Purchaser\"). Pursuant to the terms of the Transaction Agreement, the Purchaser commenced a tender offer for all the issued and outstanding common shares, par value EUR 0.09 per share (the \"Shares\"), of the Issuer (the \"Offer\"), and, on December 12, 2025 (the \"Acceptance Time\"), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer as of the Acceptance Time in exchange for a cash payment equal to $97.00 per Share, without interest and less applicable withholding taxes (the \"Offer Consideration\"), which Offer Consideration will be paid as soon as practicable following the Acceptance Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was cancelled pursuant to the Transaction Agreement in exchange for cash (without interest and net of applicable withholding tax and other applicable deductions) in an amount equal to the product of (i) the amount by which the Offer Consideration exceeds the applicable exercise price per Share of such option and (ii) the aggregate number of Shares underlying such option."}],"balance_after":0,"derivative":{"exercise_price":48.73,"expiration_date":"2034-05-07","underlying":"Common Shares","underlying_shares":8844},"source":{"system":"sec-edgar","filing":"0001193125-25-317939","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1620368/000119312525317939/ownership.xml","form_type":"4"}},{"id":970677,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2025-12-12T23:54:53.000Z","date":"2025-12-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":13193,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 29, 2025, Merus N.V. (the \"Issuer\") entered into a transaction agreement (as it may be amended, supplemented or otherwise modified from time to time, the \"Transaction Agreement\") with Genmab A/S (\"Genmab\") and its wholly owned subsidiary, Genmab Holding II B.V. (the \"Purchaser\"). Pursuant to the terms of the Transaction Agreement, the Purchaser commenced a tender offer for all the issued and outstanding common shares, par value EUR 0.09 per share (the \"Shares\"), of the Issuer (the \"Offer\"), and, on December 12, 2025 (the \"Acceptance Time\"), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer as of the Acceptance Time in exchange for a cash payment equal to $97.00 per Share, without interest and less applicable withholding taxes (the \"Offer Consideration\"), which Offer Consideration will be paid as soon as practicable following the Acceptance Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was cancelled pursuant to the Transaction Agreement in exchange for cash (without interest and net of applicable withholding tax and other applicable deductions) in an amount equal to the product of (i) the amount by which the Offer Consideration exceeds the applicable exercise price per Share of such option and (ii) the aggregate number of Shares underlying such option."}],"balance_after":0,"derivative":{"exercise_price":41.6,"expiration_date":"2035-05-22","underlying":"Common Shares","underlying_shares":13193},"source":{"system":"sec-edgar","filing":"0001193125-25-317939","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620368/000119312525317939/ownership.xml","form_type":"4"}},{"id":1004612,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-11-07T21:28:31.000Z","date":"2025-11-05","kind":"grant","planned":false,"acquired":true,"shares":121285,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award vests over a one year period equally one-twelfth per month, subject to Reporting Person's continued service to the Company on each vesting date."}],"balance_after":121285,"derivative":{"exercise_price":1.39,"expiration_date":"2035-11-04","underlying":"Common Stock","underlying_shares":121285},"source":{"system":"sec-edgar","filing":"0001620368-25-000005","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620368/000162036825000005/primarydocument.xml","form_type":"4"}},{"id":1101115,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-27T01:00:06.000Z","date":"2025-06-25","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this stock option shall vest in full upon the earlier to occur of (i) June 25, 2026 and (ii) the date of the next annual meeting of the Issuer's stockholders."}],"balance_after":16000,"derivative":{"exercise_price":46.47,"expiration_date":"2035-06-24","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0000950170-25-090580","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000095017025090580/ownership.xml","form_type":"4"}},{"id":1107465,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-06-17T21:03:18.000Z","date":"2025-06-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":12600,"price":3.58,"value":45108.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of Common Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted share units previously granted."}],"balance_after":108286,"source":{"system":"sec-edgar","filing":"0001628280-25-031894","document":"wk-form4_1750194190.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620368/000162828025031894/wk-form4_1750194190.xml","form_type":"4"}},{"id":1111009,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-06-13T20:15:50.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award will fully vest upon the earlier of (a) the Issuer's next annual stockholder meeting, or (b) the one-year anniversary of the grant date, such to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":38000,"derivative":{"exercise_price":1.04,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0001562180-25-004798","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620368/000156218025004798/primarydocument.xml","form_type":"4"}},{"id":1120886,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-06-05T21:12:04.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the annual grant of restricted stock units (\"RSUs\") made under the Issuer's 2019 Equity Incentive Plan for service as a Director. The RSUs vest one year from the grant date, subject to the Reporting Person's\ncontinued service to the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":120886,"source":{"system":"sec-edgar","filing":"0001628280-25-029739","document":"wk-form4_1749157895.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620368/000162828025029739/wk-form4_1749157895.xml","form_type":"4"}},{"id":1132924,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2025-05-27T12:00:10.000Z","date":"2025-05-22","kind":"grant","planned":false,"acquired":true,"shares":13193,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest over a one-year period commencing on May 22, 2025 in 12 equal monthly installments."}],"balance_after":13193,"derivative":{"exercise_price":41.6,"expiration_date":"2035-05-22","underlying":"Common Shares","underlying_shares":13193},"source":{"system":"sec-edgar","filing":"0000950170-25-077384","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620368/000095017025077384/ownership.xml","form_type":"4"}},{"id":1473315,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-20T21:00:03.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this stock option shall vest in full upon the earlier to occur of (i) June 18, 2025 and (ii) the date of the next annual meeting of the Issuer's stockholders."}],"balance_after":16000,"derivative":{"exercise_price":31.2,"expiration_date":"2034-06-17","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0000950170-24-075707","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000095017024075707/ownership.xml","form_type":"4"}},{"id":1474582,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-06-19T01:37:20.000Z","date":"2024-06-17","kind":"sale","planned":false,"acquired":false,"shares":6995,"price":2.89,"value":20215.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents Common Shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units."}],"balance_after":80886,"source":{"system":"sec-edgar","filing":"0001628280-24-028988","document":"wk-form4_1718761032.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620368/000162828024028988/wk-form4_1718761032.xml","form_type":"4"}},{"id":1474581,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2024-06-18T20:14:18.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":23500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award will fully vest upon the earlier of (a) the Issuer's next annual stockholder meeting, or (b) the one-year anniversary of the grant date, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":23500,"derivative":{"exercise_price":3.9,"expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":23500},"source":{"system":"sec-edgar","filing":"0001562180-24-005163","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620368/000156218024005163/primarydocument.xml","form_type":"4"}},{"id":1478463,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-06-14T21:29:35.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the annual grant of restricted stock units (\"RSUs\") made under the Issuer's 2019 Equity Incentive Plan for service as a Director. The RSUs vest one year from the grant date, subject to the Reporting Person's continued service to the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":87881,"source":{"system":"sec-edgar","filing":"0001628280-24-028347","document":"wk-form4_1718400565.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620368/000162828024028347/wk-form4_1718400565.xml","form_type":"4"}},{"id":1521815,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2024-05-09T20:30:35.000Z","date":"2024-05-07","kind":"grant","planned":false,"acquired":true,"shares":8844,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest over a one-year period commencing May 7, 2024 in 12 equal monthly installments."}],"balance_after":8844,"derivative":{"exercise_price":48.73,"expiration_date":"2034-05-07","underlying":"Common Shares","underlying_shares":8844},"source":{"system":"sec-edgar","filing":"0000950170-24-057083","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620368/000095017024057083/ownership.xml","form_type":"4"}},{"id":1847492,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2023-06-21T20:16:10.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":23500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award will fully vest upon the earlier of (a) the Issuer's next annual stockholder meeting, or (b) the one-year anniversary of the grant date, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":23500,"derivative":{"exercise_price":5.56,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":23500},"source":{"system":"sec-edgar","filing":"0001209191-23-038780","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620368/000120919123038780/doc4.xml","form_type":"4"}},{"id":1849735,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-20T20:16:32.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this stock option shall vest in full upon the earlier to occur of (i) June 15, 2024 and (ii) the date of the next annual meeting of the Issuer's stockholders."}],"balance_after":12000,"derivative":{"exercise_price":27.67,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0000899243-23-015969","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000089924323015969/doc4.xml","form_type":"4"}},{"id":1858265,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share option (right to buy)","published_at":"2023-06-12T20:13:12.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":14414,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest over a one-year period commencing June 8, 2023 in 12 equal monthly installments."}],"balance_after":14414,"derivative":{"exercise_price":23.29,"expiration_date":"2033-06-08","underlying":"Common Shares","underlying_shares":14414},"source":{"system":"sec-edgar","filing":"0001209191-23-036258","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620368/000120919123036258/doc4.xml","form_type":"4"}},{"id":2125817,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-11-03T23:22:53.000Z","date":"2022-11-03","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in thirty-six (36) equal monthly installments over three (3) years beginning on November 3, 2022."}],"balance_after":24000,"derivative":{"exercise_price":30.92,"expiration_date":"2032-11-02","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0000899243-22-034988","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000089924322034988/doc4.xml","form_type":"4"}},{"id":2223734,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2022-06-22T20:14:17.000Z","date":"2022-06-17","kind":"grant","acquired":true,"shares":34300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award will fully vest upon the earlier of (a) the Issuer's next annual stockholder meeting, or (b) the one-year anniversary of the grant date, such to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":34300,"derivative":{"exercise_price":4.74,"expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":34300},"source":{"system":"sec-edgar","filing":"0001562180-22-005299","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620368/000156218022005299/primarydocument.xml","form_type":"4"}},{"id":2246944,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share option (right to buy)","published_at":"2022-06-02T20:05:50.000Z","date":"2022-05-31","kind":"grant","acquired":true,"shares":16604,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest over a one-year period commencing May 31, 2022 in 12 equal monthly installments."}],"balance_after":16604,"derivative":{"exercise_price":18.56,"expiration_date":"2032-05-31","underlying":"Common Shares","underlying_shares":16604},"source":{"system":"sec-edgar","filing":"0000899243-22-020667","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620368/000089924322020667/doc4.xml","form_type":"4"}},{"id":2442761,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2022-01-05T22:11:42.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":11206,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 1/12 of the total shares monthly beginning on November 13, 2021 until fully vested, subject to the Reporting Person's provision of service to the Issuer on the vesting date."}],"balance_after":11206,"derivative":{"exercise_price":13.22,"expiration_date":"2032-01-02","underlying":"Common Stock","underlying_shares":11206},"source":{"system":"sec-edgar","filing":"0001209191-22-001795","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620368/000120919122001795/doc4.xml","form_type":"4"}},{"id":2542161,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-10-14T22:56:26.000Z","date":"2021-10-13","kind":"grant","acquired":true,"shares":8022,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 1/12 of the total shares monthly beginning on November 13, 2021 until fully vested, subject to the Reporting Person's provision of service to the Issuer on the vesting date."}],"balance_after":8022,"derivative":{"exercise_price":15.81,"expiration_date":"2031-10-12","underlying":"Common Stock","underlying_shares":8022},"source":{"system":"sec-edgar","filing":"0001209191-21-060506","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620368/000120919121060506/doc4.xml","form_type":"4"}},{"id":2658239,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-06-22T21:42:57.000Z","date":"2021-06-18","kind":"grant","acquired":true,"shares":23344,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award will fully vest upon the earlier of (a) the Issuer's next annual stockholder meeting, or (b) the one-year anniversary of the grant date, such to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":23344,"derivative":{"exercise_price":31.02,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":23344},"source":{"system":"sec-edgar","filing":"0001209191-21-042476","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620368/000120919121042476/doc4.xml","form_type":"4"}},{"id":2685754,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share option (right to buy)","published_at":"2021-06-02T20:10:51.000Z","date":"2021-05-28","kind":"grant","acquired":true,"shares":6120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest over a one-year period commencing May 28, 2021 in 12 equal monthly installments."}],"balance_after":6120,"derivative":{"exercise_price":21.15,"expiration_date":"2031-05-28","underlying":"Common Shares","underlying_shares":6120},"source":{"system":"sec-edgar","filing":"0000899243-21-021548","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620368/000089924321021548/doc4.xml","form_type":"4"}},{"id":3021521,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2020-09-28T23:37:02.000Z","date":"2020-09-24","kind":"grant","acquired":true,"shares":3458,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as of 1/36 of the total shares monthly beginning on September 24, 2020 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":3458,"derivative":{"exercise_price":19,"expiration_date":"2030-09-23","underlying":"Common Stock","underlying_shares":3458},"source":{"system":"sec-edgar","filing":"0001209191-20-052267","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620368/000120919120052267/doc4.xml","form_type":"4"}},{"id":3090656,"issuer":{"id":70740,"kind":"organization","name":"Merus N.V.","symbol":"MRUS"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2020-07-02T20:00:54.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":8631,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest over a one-year period commencing June 30, 2020 in 12 equal monthly installments."}],"balance_after":8631,"derivative":{"exercise_price":16.09,"expiration_date":"2030-06-30","underlying":"Common Shares","underlying_shares":8631},"source":{"system":"sec-edgar","filing":"0001209191-20-040209","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620368/000120919120040209/doc4.xml","form_type":"4"}},{"id":3453490,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-30T20:05:17.000Z","date":"2019-07-30","kind":"disposition_to_issuer","acquired":false,"shares":289500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents shares of Company common stock underlying compensatory options to purchase shares of Company common stock, whether or not vested and which have a per share exercise price that is less than $48.00 (each, an \"In the Money Option\"). Pursuant to the terms of the Merger Agreement, each In the Money Option held by the Reporting Person was cancelled and converted into the right to a cash payment equal to (i) the excess, if any, of (A) $48.00 over (B) the exercise price payable per share of Company common stock under such In the Money Option, multiplied by (ii) the total number of shares of Company common stock subject to such In the Money Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option provided for vesting in four equal annual installments beginning on December 16, 2019."}],"balance_after":0,"derivative":{"exercise_price":15.97,"expiration_date":"2028-12-16","underlying":"Common Stock","underlying_shares":289500},"source":{"system":"sec-edgar","filing":"0001209191-19-043784","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000120919119043784/doc4.xml","form_type":"4"}},{"id":3453489,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-30T20:05:17.000Z","date":"2019-07-30","kind":"disposition_to_issuer","acquired":false,"shares":289500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents shares of Company common stock underlying compensatory options to purchase shares of Company common stock, whether or not vested and which have a per share exercise price that is less than $48.00 (each, an \"In the Money Option\"). Pursuant to the terms of the Merger Agreement, each In the Money Option held by the Reporting Person was cancelled and converted into the right to a cash payment equal to (i) the excess, if any, of (A) $48.00 over (B) the exercise price payable per share of Company common stock under such In the Money Option, multiplied by (ii) the total number of shares of Company common stock subject to such In the Money Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option provided for vesting in four equal annual installments beginning on December 16, 2018."}],"balance_after":0,"derivative":{"exercise_price":10.92,"expiration_date":"2027-12-16","underlying":"Common Stock","underlying_shares":289500},"source":{"system":"sec-edgar","filing":"0001209191-19-043784","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000120919119043784/doc4.xml","form_type":"4"}},{"id":3453488,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-30T20:05:17.000Z","date":"2019-07-30","kind":"disposition_to_issuer","acquired":false,"shares":270828,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents shares of Company common stock underlying compensatory options to purchase shares of Company common stock, whether or not vested and which have a per share exercise price that is less than $48.00 (each, an \"In the Money Option\"). Pursuant to the terms of the Merger Agreement, each In the Money Option held by the Reporting Person was cancelled and converted into the right to a cash payment equal to (i) the excess, if any, of (A) $48.00 over (B) the exercise price payable per share of Company common stock under such In the Money Option, multiplied by (ii) the total number of shares of Company common stock subject to such In the Money Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option provided for vesting in four equal annual installments beginning on December 26, 2017."}],"balance_after":0,"derivative":{"exercise_price":8.79,"expiration_date":"2026-12-27","underlying":"Common Stock","underlying_shares":270828},"source":{"system":"sec-edgar","filing":"0001209191-19-043784","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000120919119043784/doc4.xml","form_type":"4"}},{"id":3453487,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-30T20:05:17.000Z","date":"2019-07-30","kind":"disposition_to_issuer","acquired":false,"shares":187500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents shares of Company common stock underlying compensatory options to purchase shares of Company common stock, whether or not vested and which have a per share exercise price that is less than $48.00 (each, an \"In the Money Option\"). Pursuant to the terms of the Merger Agreement, each In the Money Option held by the Reporting Person was cancelled and converted into the right to a cash payment equal to (i) the excess, if any, of (A) $48.00 over (B) the exercise price payable per share of Company common stock under such In the Money Option, multiplied by (ii) the total number of shares of Company common stock subject to such In the Money Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option provided for vesting in four equal annual installments beginning on April 1, 2017."}],"balance_after":0,"derivative":{"exercise_price":3,"expiration_date":"2026-04-01","underlying":"Common Stock","underlying_shares":187500},"source":{"system":"sec-edgar","filing":"0001209191-19-043784","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000120919119043784/doc4.xml","form_type":"4"}},{"id":3453486,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-30T20:05:17.000Z","date":"2019-07-30","kind":"disposition_to_issuer","acquired":false,"shares":87500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents shares of Company common stock underlying compensatory options to purchase shares of Company common stock, whether or not vested and which have a per share exercise price that is less than $48.00 (each, an \"In the Money Option\"). Pursuant to the terms of the Merger Agreement, each In the Money Option held by the Reporting Person was cancelled and converted into the right to a cash payment equal to (i) the excess, if any, of (A) $48.00 over (B) the exercise price payable per share of Company common stock under such In the Money Option, multiplied by (ii) the total number of shares of Company common stock subject to such In the Money Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option provided for vesting in four equal annual installments beginning on April 1, 2016."}],"balance_after":0,"derivative":{"exercise_price":7.3,"expiration_date":"2025-04-01","underlying":"Common Stock","underlying_shares":87500},"source":{"system":"sec-edgar","filing":"0001209191-19-043784","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000120919119043784/doc4.xml","form_type":"4"}},{"id":3453485,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-07-30T20:05:17.000Z","date":"2019-07-30","kind":"disposition_to_issuer","acquired":false,"shares":114821,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 14, 2019, Array BioPharma Inc. (the \"Company\") entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Pfizer Inc. (\"Pfizer\") and Arlington Acquisition Sub Inc., a wholly owned subsidiary of Pfizer (\"Purchaser\"). Pursuant to the terms of the Merger Agreement, each share of Company common stock held by the Reporting Person was cancelled and converted into the right to receive an amount in cash equal to $48.00, without interest and subject to any required withholding of taxes."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On July 30, 2019, Purchaser merged with and into the Company pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Company being the surviving corporation and becoming a wholly-owned subsidiary of Pfizer. Pursuant to the terms of the Merger Agreement, each share of Company common stock was converted into the right to receive an amount in cash equal to $48.00, without interest and subject to any required withholding of taxes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents shares of Company common stock underlying each restricted stock unit (a \"Company RSU\") held by the Reporting Person, whether or not vested. Pursuant to the terms of the Merger Agreement, each Company RSU held by the Reporting Person was converted into the right to receive an amount in cash equal to the product of (i) $48.00 and (ii) the number of shares of Company common stock subject to such Company RSU."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-043784","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000120919119043784/doc4.xml","form_type":"4"}},{"id":3453484,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-07-30T20:05:17.000Z","date":"2019-07-30","kind":"disposition_to_issuer","acquired":false,"shares":209543,"price":48,"value":10058064.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 14, 2019, Array BioPharma Inc. (the \"Company\") entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Pfizer Inc. (\"Pfizer\") and Arlington Acquisition Sub Inc., a wholly owned subsidiary of Pfizer (\"Purchaser\"). Pursuant to the terms of the Merger Agreement, each share of Company common stock held by the Reporting Person was cancelled and converted into the right to receive an amount in cash equal to $48.00, without interest and subject to any required withholding of taxes."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On July 30, 2019, Purchaser merged with and into the Company pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Company being the surviving corporation and becoming a wholly-owned subsidiary of Pfizer. Pursuant to the terms of the Merger Agreement, each share of Company common stock was converted into the right to receive an amount in cash equal to $48.00, without interest and subject to any required withholding of taxes."}],"balance_after":114821,"source":{"system":"sec-edgar","filing":"0001209191-19-043784","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000120919119043784/doc4.xml","form_type":"4"}},{"id":3499183,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-06T16:02:02.000Z","date":"2019-06-04","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in four equal annual installments beginning on April 1, 2016."}],"balance_after":87500,"derivative":{"exercise_price":7.3,"expiration_date":"2025-04-01","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001562180-19-003387","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019003387/primarydocument.xml","form_type":"4"}},{"id":3499182,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-06-06T16:02:02.000Z","date":"2019-06-04","kind":"sale","acquired":false,"shares":100000,"price":28.51,"value":2851000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for these shares is the weighted average sale price of transactions made at prices from $28.50 to $28.59. Details of actual prices for shares sold are available from the Issuer upon request."}],"balance_after":209543,"source":{"system":"sec-edgar","filing":"0001562180-19-003387","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019003387/primarydocument.xml","form_type":"4"}},{"id":3499181,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-06-06T16:02:02.000Z","date":"2019-06-04","kind":"exercise","acquired":true,"shares":100000,"price":7.3,"value":730000.0,"ownership":{"direct":true},"balance_after":309543,"source":{"system":"sec-edgar","filing":"0001562180-19-003387","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019003387/primarydocument.xml","form_type":"4"}},{"id":3505126,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-03T16:03:11.000Z","date":"2019-06-03","kind":"exercise","acquired":false,"shares":36134,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested in four equal annual installments beginning on September 22, 2015."}],"balance_after":0,"derivative":{"exercise_price":3.65,"expiration_date":"2024-09-22","underlying":"Common Stock","underlying_shares":36134},"source":{"system":"sec-edgar","filing":"0001562180-19-003220","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019003220/primarydocument.xml","form_type":"4"}},{"id":3505125,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-03T16:03:11.000Z","date":"2019-05-30","kind":"exercise","acquired":false,"shares":15728,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested in four equal annual installments beginning on September 22, 2015."}],"balance_after":36134,"derivative":{"exercise_price":3.65,"expiration_date":"2024-09-22","underlying":"Common Stock","underlying_shares":15728},"source":{"system":"sec-edgar","filing":"0001562180-19-003220","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019003220/primarydocument.xml","form_type":"4"}},{"id":3505124,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-06-03T16:03:11.000Z","date":"2019-06-03","kind":"sale","acquired":false,"shares":36134,"price":27.5845,"value":996738.323,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for these shares is the weighted average sale price of transactions made at prices from $27.50 to $27.67. Details of actual prices for shares sold are available from the Issuer upon request."}],"balance_after":209543,"source":{"system":"sec-edgar","filing":"0001562180-19-003220","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019003220/primarydocument.xml","form_type":"4"}},{"id":3505123,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-06-03T16:03:11.000Z","date":"2019-06-03","kind":"exercise","acquired":true,"shares":36134,"price":3.65,"value":131889.1,"ownership":{"direct":true},"balance_after":245677,"source":{"system":"sec-edgar","filing":"0001562180-19-003220","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019003220/primarydocument.xml","form_type":"4"}},{"id":3505122,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-06-03T16:03:11.000Z","date":"2019-05-30","kind":"sale","acquired":false,"shares":15728,"price":27.5,"value":432520.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":209543,"source":{"system":"sec-edgar","filing":"0001562180-19-003220","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019003220/primarydocument.xml","form_type":"4"}},{"id":3505121,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-06-03T16:03:11.000Z","date":"2019-05-30","kind":"exercise","acquired":true,"shares":15728,"price":3.65,"value":57407.2,"ownership":{"direct":true},"balance_after":225271,"source":{"system":"sec-edgar","filing":"0001562180-19-003220","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019003220/primarydocument.xml","form_type":"4"}},{"id":3510588,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2019-05-28T16:04:52.000Z","date":"2019-05-28","kind":"exercise","acquired":false,"shares":46766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested in four equal annual installments beginning on September 22, 2015."}],"balance_after":51862,"derivative":{"exercise_price":3.65,"expiration_date":"2024-09-22","underlying":"Common Stock","underlying_shares":46766},"source":{"system":"sec-edgar","filing":"0001562180-19-003124","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019003124/primarydocument.xml","form_type":"4"}},{"id":3510587,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-28T16:04:52.000Z","date":"2019-05-23","kind":"exercise","acquired":false,"shares":40634,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested in four equal annual installments beginning on September 22, 2015."}],"balance_after":98628,"derivative":{"exercise_price":3.65,"expiration_date":"2024-09-22","underlying":"Common Stock","underlying_shares":40634},"source":{"system":"sec-edgar","filing":"0001562180-19-003124","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019003124/primarydocument.xml","form_type":"4"}},{"id":3510586,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-05-28T16:04:52.000Z","date":"2019-05-28","kind":"sale","acquired":false,"shares":74915,"price":27.003,"value":2022929.745,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for these shares is the weighted average sale price of transactions made at prices from $26.75 to $27.10. Details of actual prices for shares sold are available from the Issuer upon request."}],"balance_after":209543,"source":{"system":"sec-edgar","filing":"0001562180-19-003124","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019003124/primarydocument.xml","form_type":"4"}},{"id":3510585,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-05-28T16:04:52.000Z","date":"2019-05-28","kind":"exercise","acquired":true,"shares":46766,"price":3.65,"value":170695.9,"ownership":{"direct":true},"balance_after":284458,"source":{"system":"sec-edgar","filing":"0001562180-19-003124","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019003124/primarydocument.xml","form_type":"4"}},{"id":3510584,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-05-28T16:04:52.000Z","date":"2019-05-23","kind":"sale","acquired":false,"shares":40634,"price":26.5011,"value":1076845.6974,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for these shares is the weighted average sale price of transactions made at prices from $26.50 to $26.51. Details of actual prices for shares sold are available from the Issuer upon request."}],"balance_after":237692,"source":{"system":"sec-edgar","filing":"0001562180-19-003124","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019003124/primarydocument.xml","form_type":"4"}},{"id":3510583,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-05-28T16:04:52.000Z","date":"2019-05-23","kind":"exercise","acquired":true,"shares":40634,"price":3.65,"value":148314.1,"ownership":{"direct":true},"balance_after":278326,"source":{"system":"sec-edgar","filing":"0001562180-19-003124","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019003124/primarydocument.xml","form_type":"4"}},{"id":3513756,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-23T17:26:11.000Z","date":"2019-05-21","kind":"exercise","acquired":false,"shares":12600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested in four equal annual installments beginning on September 22, 2015."}],"balance_after":139262,"derivative":{"exercise_price":3.65,"expiration_date":"2024-09-22","underlying":"Common Stock","underlying_shares":12600},"source":{"system":"sec-edgar","filing":"0001562180-19-003078","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019003078/primarydocument.xml","form_type":"4"}},{"id":3513755,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-05-23T17:26:11.000Z","date":"2019-05-21","kind":"sale","acquired":false,"shares":12600,"price":26.5,"value":333900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":237692,"source":{"system":"sec-edgar","filing":"0001562180-19-003078","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019003078/primarydocument.xml","form_type":"4"}},{"id":3513754,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-05-23T17:26:11.000Z","date":"2019-05-21","kind":"exercise","acquired":true,"shares":12600,"price":3.65,"value":45990.0,"ownership":{"direct":true},"balance_after":250292,"source":{"system":"sec-edgar","filing":"0001562180-19-003078","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019003078/primarydocument.xml","form_type":"4"}},{"id":3566127,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2019-04-03T16:30:45.000Z","date":"2019-04-01","kind":"exercise","acquired":false,"shares":7813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest and will be settled in stock in four equal annual installments beginning April 1, 2016."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest and will be settled in stock in four equal annual installments beginning April 1, 2016."}],"balance_after":7813,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":7813},"source":{"system":"sec-edgar","filing":"0001562180-19-002181","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019002181/primarydocument.xml","form_type":"4"}},{"id":3566126,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2019-04-03T16:30:45.000Z","date":"2019-04-01","kind":"exercise","acquired":false,"shares":7813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vested and settled in stock in four equal annual installments beginning April 1, 2015."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vested and settled in stock in four equal annual installments beginning April 1, 2015."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":7813},"source":{"system":"sec-edgar","filing":"0001562180-19-002181","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019002181/primarydocument.xml","form_type":"4"}},{"id":3566125,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-04-03T16:30:45.000Z","date":"2019-04-01","kind":"tax_withholding","acquired":false,"shares":6932,"price":24.6,"value":170527.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to satisfy tax withholding obligations of the reporting person."}],"balance_after":237692,"source":{"system":"sec-edgar","filing":"0001562180-19-002181","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019002181/primarydocument.xml","form_type":"4"}},{"id":3566124,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-04-03T16:30:45.000Z","date":"2019-04-01","kind":"exercise","acquired":true,"shares":15626,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issued upon settlement of Restricted Stock Units (\"RSUs\") granted on April 1, 2015 and April 1, 2016 as a result of the vesting of one fourth of such RSUs."}],"balance_after":244624,"source":{"system":"sec-edgar","filing":"0001562180-19-002181","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019002181/primarydocument.xml","form_type":"4"}},{"id":3714477,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-01-02T16:32:13.000Z","date":"2018-12-27","kind":"sale","acquired":false,"shares":6268,"price":14.0541,"value":88091.0988,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for these shares is the weighted average sale price of transactions made at prices from $14.00 to $14.25. Details of actual prices for shares sold are available from the Issuer upon request."}],"balance_after":228998,"source":{"system":"sec-edgar","filing":"0001562180-19-000071","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218019000071/primarydocument.xml","form_type":"4"}},{"id":3727449,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2018-12-18T19:49:19.000Z","date":"2018-12-16","kind":"exercise","acquired":false,"shares":12062,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vested and were settled in common stock on December 16, 2018."}],"balance_after":36188,"derivative":{"exercise_price":0,"expiration_date":"2021-12-17","underlying":"Common Stock","underlying_shares":12062},"source":{"system":"sec-edgar","filing":"0001562180-18-005031","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018005031/primarydocument.xml","form_type":"4"}},{"id":3727448,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2018-12-18T19:49:19.000Z","date":"2018-12-16","kind":"exercise","acquired":false,"shares":11284,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vested and were settled in common stock on December 16, 2018."}],"balance_after":22570,"derivative":{"exercise_price":0,"expiration_date":"2020-12-16","underlying":"Common Stock","underlying_shares":11284},"source":{"system":"sec-edgar","filing":"0001562180-18-005031","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018005031/primarydocument.xml","form_type":"4"}},{"id":3727447,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-18T19:49:19.000Z","date":"2018-12-14","kind":"grant","acquired":true,"shares":289500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vest in four equal annual installments beginning on December 16, 2019."}],"balance_after":289500,"derivative":{"exercise_price":15.97,"expiration_date":"2028-12-16","underlying":"Common Stock","underlying_shares":289500},"source":{"system":"sec-edgar","filing":"0001562180-18-005031","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018005031/primarydocument.xml","form_type":"4"}},{"id":3727446,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2018-12-18T19:49:19.000Z","date":"2018-12-14","kind":"grant","acquired":true,"shares":48250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"RSUs awarded to the reporting person for no additional cash consideration and each represents a contingent right to receive one share of common stock. The RSUs vest and will be settled in common stock in four equal annual installments beginning on December 16, 2019."}],"balance_after":48250,"derivative":{"exercise_price":0,"expiration_date":"2022-12-20","underlying":"Common Stock","underlying_shares":48250},"source":{"system":"sec-edgar","filing":"0001562180-18-005031","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018005031/primarydocument.xml","form_type":"4"}},{"id":3727445,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-12-18T19:49:19.000Z","date":"2018-12-16","kind":"tax_withholding","acquired":false,"shares":10378,"price":15.97,"value":165736.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to satisfy tax withholding obligations of the reporting person."}],"balance_after":235266,"source":{"system":"sec-edgar","filing":"0001562180-18-005031","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018005031/primarydocument.xml","form_type":"4"}},{"id":3727444,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-12-18T19:49:19.000Z","date":"2018-12-16","kind":"exercise","acquired":true,"shares":23346,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issued upon settlement of Restricted Stock Units (\"RSUs\") granted on December 27, 2016 and December 16, 2017, as a result of the vesting of one fourth of such RSUs."}],"balance_after":245644,"source":{"system":"sec-edgar","filing":"0001562180-18-005031","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018005031/primarydocument.xml","form_type":"4"}},{"id":3741891,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-06T16:02:55.000Z","date":"2018-12-03","kind":"exercise","acquired":false,"shares":127397,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested in four equal annual installments beginning on September 22, 2015."}],"balance_after":151862,"derivative":{"exercise_price":3.65,"expiration_date":"2024-09-22","underlying":"Common Stock","underlying_shares":127397},"source":{"system":"sec-edgar","filing":"0001562180-18-004844","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018004844/primarydocument.xml","form_type":"4"}},{"id":3741890,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-12-06T16:02:55.000Z","date":"2018-12-03","kind":"sale","acquired":false,"shares":115185,"price":16.2091,"value":1867045.1835,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for these shares is the weighted average sale price of transactions made at prices from $16.00 to $16.435. Details of actual prices for shares sold are available from the Issuer upon request."}],"balance_after":222298,"source":{"system":"sec-edgar","filing":"0001562180-18-004844","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018004844/primarydocument.xml","form_type":"4"}},{"id":3741889,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-12-06T16:02:55.000Z","date":"2018-12-03","kind":"exercise","acquired":true,"shares":127397,"price":3.65,"value":464999.05,"ownership":{"direct":true},"balance_after":337483,"source":{"system":"sec-edgar","filing":"0001562180-18-004844","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018004844/primarydocument.xml","form_type":"4"}},{"id":3825798,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-09-05T16:18:16.000Z","date":"2018-09-04","kind":"sale","acquired":false,"shares":9687,"price":15.375,"value":148937.625,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for these shares is the weighted average sale price of transactions made at prices from $15.37 to $15.38. Details of actual prices for shares sold are available from the Issuer upon request."}],"balance_after":210086,"source":{"system":"sec-edgar","filing":"0001562180-18-003834","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018003834/primarydocument.xml","form_type":"4"}},{"id":3880621,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2018-06-29T16:21:47.000Z","date":"2018-06-27","kind":"exercise","acquired":false,"shares":17440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"RSUs representing 17,440 shares of common stock vested upon the achievement of a second milestone relating to the return of rights to binimetinib to the Issuer on or prior to the fourth anniversary of the grant date, subject to continued service with the Issuer as of the vesting date."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2018-08-18","underlying":"Common Stock","underlying_shares":17440},"source":{"system":"sec-edgar","filing":"0001562180-18-003128","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018003128/primarydocument.xml","form_type":"4"}},{"id":3880620,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-06-29T16:21:47.000Z","date":"2018-06-27","kind":"tax_withholding","acquired":false,"shares":7753,"price":18.5,"value":143430.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld to satisfy tax withholding obligations of the reporting person."}],"balance_after":219773,"source":{"system":"sec-edgar","filing":"0001562180-18-003128","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018003128/primarydocument.xml","form_type":"4"}},{"id":3880619,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-06-29T16:21:47.000Z","date":"2018-06-27","kind":"exercise","acquired":true,"shares":17440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares released on vesting of Restricted Stock Units (\"RSUs\") granted to the reporting person on August 18, 2014. The grant of these RSUs was previously reported on Table II."}],"balance_after":227526,"source":{"system":"sec-edgar","filing":"0001562180-18-003128","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018003128/primarydocument.xml","form_type":"4"}},{"id":3886278,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-21T16:20:17.000Z","date":"2018-06-19","kind":"exercise","acquired":false,"shares":77576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested in four equal annual installments beginning on September 22, 2015."}],"balance_after":279259,"derivative":{"exercise_price":3.65,"expiration_date":"2024-09-22","underlying":"Common Stock","underlying_shares":77576},"source":{"system":"sec-edgar","filing":"0001562180-18-003074","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018003074/primarydocument.xml","form_type":"4"}},{"id":3886277,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-06-21T16:20:17.000Z","date":"2018-06-19","kind":"sale","acquired":false,"shares":77576,"price":18.76,"value":1455325.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for these shares is the weighted average sale price of transactions made at prices from $18.75 to $18.845. Details of actual prices for shares sold are available from the Issuer upon request."}],"balance_after":210086,"source":{"system":"sec-edgar","filing":"0001562180-18-003074","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018003074/primarydocument.xml","form_type":"4"}},{"id":3886276,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-06-21T16:20:17.000Z","date":"2018-06-19","kind":"exercise","acquired":true,"shares":77576,"price":3.65,"value":283152.4,"ownership":{"direct":true},"balance_after":287662,"source":{"system":"sec-edgar","filing":"0001562180-18-003074","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018003074/primarydocument.xml","form_type":"4"}},{"id":3892800,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-15T16:25:02.000Z","date":"2018-06-13","kind":"exercise","acquired":false,"shares":22424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested in four equal annual installments beginning on September 22, 2015."}],"balance_after":356835,"derivative":{"exercise_price":3.65,"expiration_date":"2024-09-22","underlying":"Common Stock","underlying_shares":22424},"source":{"system":"sec-edgar","filing":"0001562180-18-003024","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018003024/primarydocument.xml","form_type":"4"}},{"id":3892799,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-06-15T16:25:02.000Z","date":"2018-06-13","kind":"sale","acquired":false,"shares":22424,"price":18.75,"value":420450.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":210086,"source":{"system":"sec-edgar","filing":"0001562180-18-003024","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018003024/primarydocument.xml","form_type":"4"}},{"id":3892798,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-06-15T16:25:02.000Z","date":"2018-06-13","kind":"exercise","acquired":true,"shares":22424,"price":3.65,"value":81847.6,"ownership":{"direct":true},"balance_after":232510,"source":{"system":"sec-edgar","filing":"0001562180-18-003024","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018003024/primarydocument.xml","form_type":"4"}},{"id":3973815,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2018-04-03T18:49:08.000Z","date":"2018-04-01","kind":"exercise","acquired":false,"shares":7812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The remaining RSUs vest and will be settled in stock in two equal annual installments on April 1, 2019 and 2020."}],"balance_after":15626,"derivative":{"exercise_price":0,"expiration_date":"2020-04-01","underlying":"Common Stock","underlying_shares":7812},"source":{"system":"sec-edgar","filing":"0001562180-18-001804","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018001804/primarydocument.xml","form_type":"4"}},{"id":3973814,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-04-03T18:49:08.000Z","date":"2018-04-03","kind":"sale","acquired":false,"shares":8689,"price":15.35,"value":133376.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported for these shares is the weighted average sale price. Details of actual prices for shares sold are available from the Issuer upon request."}],"balance_after":210086,"source":{"system":"sec-edgar","filing":"0001562180-18-001804","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018001804/primarydocument.xml","form_type":"4"}},{"id":3973813,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-04-03T18:49:08.000Z","date":"2018-04-01","kind":"tax_withholding","acquired":false,"shares":6936,"price":16.32,"value":113195.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld to satisfy tax withholding obligations of the reporting person in connection with the vesting of RSUs held by the reporting person."}],"balance_after":218775,"source":{"system":"sec-edgar","filing":"0001562180-18-001804","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018001804/primarydocument.xml","form_type":"4"}},{"id":3973812,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-04-03T18:49:08.000Z","date":"2018-04-01","kind":"exercise","acquired":true,"shares":7812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issued upon settlement of Restricted Stock Units (\"RSUs\") granted by the Issuer on April 1, 2016 as a result of the vesting of one fourth of such RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (i) 7,813 unvested Restricted Stock Units (\"RSUs\") awarded on April 1, 2015 to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Array BioPharma Inc. common stock and which were reported by the reporting person on Table I on a form 4 filed upon grant of the RSUs, and (ii) 7,813 shares of common stock issued upon the vesting of these RSU's on April 1, 2018."}],"balance_after":225711,"source":{"system":"sec-edgar","filing":"0001562180-18-001804","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018001804/primarydocument.xml","form_type":"4"}},{"id":4003808,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-09T17:42:17.000Z","date":"2018-03-09","kind":"exercise","acquired":false,"shares":182191,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested in four equal annual installments beginning on September 22, 2015."}],"balance_after":379259,"derivative":{"exercise_price":3.65,"expiration_date":"2024-09-22","underlying":"Common Stock","underlying_shares":182191},"source":{"system":"sec-edgar","filing":"0001562180-18-001592","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018001592/primarydocument.xml","form_type":"4"}},{"id":4003807,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-03-09T17:42:17.000Z","date":"2018-03-09","kind":"sale","acquired":false,"shares":111518,"price":17.72,"value":1976098.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for these shares is the weighted average sale price. Details of actual prices for shares sold are available from the Issuer upon request."}],"balance_after":217899,"source":{"system":"sec-edgar","filing":"0001562180-18-001592","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018001592/primarydocument.xml","form_type":"4"}},{"id":4003806,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-03-09T17:42:17.000Z","date":"2018-03-09","kind":"sale","acquired":false,"shares":44498,"price":17.7,"value":787614.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for these shares is the weighted average sale price. Details of actual prices for shares sold are available from the Issuer upon request."}],"balance_after":329417,"source":{"system":"sec-edgar","filing":"0001562180-18-001592","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018001592/primarydocument.xml","form_type":"4"}},{"id":4003805,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-03-09T17:42:17.000Z","date":"2018-03-09","kind":"exercise","acquired":true,"shares":182191,"price":3.65,"value":664997.15,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 15,625 unvested RSUs awarded on April 1, 2015 to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Array BioPharma Inc. common stock and which were reported by the reporting person on Table I on a form 4 filed upon grant of the RSUs."}],"balance_after":373915,"source":{"system":"sec-edgar","filing":"0001562180-18-001592","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218018001592/primarydocument.xml","form_type":"4"}},{"id":4126802,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-19T21:04:58.000Z","date":"2017-12-16","kind":"grant","acquired":true,"shares":289500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option vests in four equal annual installments beginning on December 16, 2018."}],"balance_after":289500,"derivative":{"exercise_price":10.92,"expiration_date":"2027-12-16","underlying":"Common Stock","underlying_shares":289500},"source":{"system":"sec-edgar","filing":"0001562180-17-003954","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218017003954/primarydocument.xml","form_type":"4"}},{"id":4126801,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2017-12-19T21:04:58.000Z","date":"2017-12-16","kind":"grant","acquired":true,"shares":48250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Consists of RSUs awarded to the reporting person for no additional cash consideration each of which represent a contingent right to receive one share of Array BioPharma Inc. common stock. The RSUs vest and will be settled in stock in four equal annual installments beginning on December 16, 2018."}],"balance_after":48250,"derivative":{"exercise_price":0,"expiration_date":"2021-12-17","underlying":"Common Stock","underlying_shares":48250},"source":{"system":"sec-edgar","filing":"0001562180-17-003954","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218017003954/primarydocument.xml","form_type":"4"}},{"id":4126800,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2017-12-19T21:04:58.000Z","date":"2017-12-16","kind":"exercise","acquired":false,"shares":11284,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"RSUs were awarded to the reporting person for no additional cash consideration and represent a contingent right to receive one share of Array BioPharma Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vested on December 16, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Consists of remaining unvested RSUs awarded to the reporting person for no additional cash consideration on December 16, 2016, which vest in three equal remaining installments beginning December 16, 2018, and represent a contingent right to receive one share of Array BioPharma Inc. common stock. The grant of these RSUs were previously reported on a Table II of a form 4 filed by the reporting person."}],"balance_after":33854,"derivative":{"expiration_date":"2020-12-16","underlying":"Common Stock","underlying_shares":11284},"source":{"system":"sec-edgar","filing":"0001562180-17-003954","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218017003954/primarydocument.xml","form_type":"4"}},{"id":4126799,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-12-19T21:04:58.000Z","date":"2017-12-16","kind":"tax_withholding","acquired":false,"shares":5310,"price":10.92,"value":57985.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld to satisfy tax withholding obligations of the reporting person."}],"balance_after":191724,"source":{"system":"sec-edgar","filing":"0001562180-17-003954","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218017003954/primarydocument.xml","form_type":"4"}},{"id":4126798,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-12-19T21:04:58.000Z","date":"2017-12-16","kind":"exercise","acquired":true,"shares":11284,"price":8.79,"value":99186.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares issued upon settlement of Restricted Stock Units (\"RSUs\") granted by the Issuer on December 27, 2016 as a result of the vesting of one fourth of such RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 15,625 unvested RSUs awarded on April 1, 2015 to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Array BioPharma Inc. common stock and which were reported by the reporting person on Table I on a form 4 filed upon grant of the RSUs."}],"balance_after":197034,"source":{"system":"sec-edgar","filing":"0001562180-17-003954","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218017003954/primarydocument.xml","form_type":"4"}},{"id":4356968,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-04-06T20:32:01.000Z","date":"2017-04-01","kind":"tax_withholding","acquired":false,"shares":7303,"price":8.94,"value":65288.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This amendment to form 4 is being filed to correct number of shares withheld to satisfy the reporting person's tax withholding obligations in connection with the vesting of Restricted Stock Units, and to correct the ending balance previously reported on a form 4 by the reporting person. No other information in such form 4 is being amended."}],"balance_after":170125,"source":{"system":"sec-edgar","filing":"0001562180-17-001487","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218017001487/primarydocument.xml","form_type":"4/A","original_submission_date":"2017-04-04"}},{"id":4362048,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2017-04-04T21:43:14.000Z","date":"2017-04-01","kind":"exercise","acquired":false,"shares":7812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest and will be settled in stock in four equal annual installments beginning April 1, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Consists of unvested RSUs awarded to the reporting person for no additional cash consideration and represent a contingent right to receive one share of Array BioPharma Inc. common stock. The grant of these RSUs were previously reported on a Table II of a form 4 filed by the reporting person."}],"balance_after":23438,"derivative":{"exercise_price":0,"expiration_date":"2020-04-01","underlying":"Common Stock","underlying_shares":7812},"source":{"system":"sec-edgar","filing":"0001562180-17-001466","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218017001466/primarydocument.xml","form_type":"4"}},{"id":4362047,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-04-04T21:43:14.000Z","date":"2017-04-01","kind":"tax_withholding","acquired":false,"shares":5022,"price":8.94,"value":44896.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld to satisfy tax withholding obligations of the reporting person in connection with the vesting of RSUs held by the reporting person."}],"balance_after":172406,"source":{"system":"sec-edgar","filing":"0001562180-17-001466","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000156218017001466/primarydocument.xml","form_type":"4"}}],"next_cursor":"2017-04-04T21:43:14.000000Z,4362047"}